Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1810854547;54548;54549 chr2:178604767;178604766;178604765chr2:179469494;179469493;179469492
N2AB1646749624;49625;49626 chr2:178604767;178604766;178604765chr2:179469494;179469493;179469492
N2A1554046843;46844;46845 chr2:178604767;178604766;178604765chr2:179469494;179469493;179469492
N2B904327352;27353;27354 chr2:178604767;178604766;178604765chr2:179469494;179469493;179469492
Novex-1916827727;27728;27729 chr2:178604767;178604766;178604765chr2:179469494;179469493;179469492
Novex-2923527928;27929;27930 chr2:178604767;178604766;178604765chr2:179469494;179469493;179469492
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: AGT
  • RefSeq wild type template codon: TCA
  • Domain: Fn3-19
  • Domain position: 44
  • Structural Position: 54
  • Q(SASA): 0.6179
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/R rs1460827160 None 0.015 N 0.201 0.145 0.124217242631 gnomAD-3.1.2 6.58E-06 None None None None N None 0 0 0 0 0 None 0 0 1.47E-05 0 0
S/R rs1460827160 None 0.015 N 0.201 0.145 0.124217242631 gnomAD-4.0.0 1.86085E-06 None None None None N None 0 0 None 0 0 None 0 0 2.5447E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0908 likely_benign 0.1023 benign -0.252 Destabilizing 0.863 D 0.208 neutral None None None None N
S/C 0.2151 likely_benign 0.2532 benign -0.237 Destabilizing 0.999 D 0.265 neutral N 0.494374565 None None N
S/D 0.4888 ambiguous 0.6131 pathogenic -0.051 Destabilizing 0.969 D 0.183 neutral None None None None N
S/E 0.5529 ambiguous 0.6639 pathogenic -0.164 Destabilizing 0.863 D 0.229 neutral None None None None N
S/F 0.319 likely_benign 0.3975 ambiguous -0.915 Destabilizing 0.997 D 0.309 neutral None None None None N
S/G 0.0935 likely_benign 0.1138 benign -0.324 Destabilizing 0.906 D 0.226 neutral N 0.483960796 None None N
S/H 0.4463 ambiguous 0.5485 ambiguous -0.759 Destabilizing 0.997 D 0.214 neutral None None None None N
S/I 0.2761 likely_benign 0.3802 ambiguous -0.195 Destabilizing 0.996 D 0.328 neutral N 0.467623029 None None N
S/K 0.6887 likely_pathogenic 0.8047 pathogenic -0.438 Destabilizing 0.079 N 0.117 neutral None None None None N
S/L 0.1403 likely_benign 0.1645 benign -0.195 Destabilizing 0.969 D 0.285 neutral None None None None N
S/M 0.2697 likely_benign 0.3267 benign 0.039 Stabilizing 0.997 D 0.216 neutral None None None None N
S/N 0.164 likely_benign 0.2361 benign -0.107 Destabilizing 0.959 D 0.219 neutral N 0.509992604 None None N
S/P 0.6305 likely_pathogenic 0.7283 pathogenic -0.188 Destabilizing 0.997 D 0.211 neutral None None None None N
S/Q 0.4924 ambiguous 0.5983 pathogenic -0.41 Destabilizing 0.939 D 0.207 neutral None None None None N
S/R 0.6185 likely_pathogenic 0.7379 pathogenic -0.153 Destabilizing 0.015 N 0.201 neutral N 0.476864253 None None N
S/T 0.0832 likely_benign 0.0897 benign -0.233 Destabilizing 0.959 D 0.237 neutral N 0.489428118 None None N
S/V 0.2266 likely_benign 0.3034 benign -0.188 Destabilizing 0.969 D 0.291 neutral None None None None N
S/W 0.5207 ambiguous 0.5867 pathogenic -0.943 Destabilizing 0.999 D 0.43 neutral None None None None N
S/Y 0.3138 likely_benign 0.4048 ambiguous -0.656 Destabilizing 0.997 D 0.311 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.